Last reviewed · How we verify
[18F]F-AraG PET imaging — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
[18F]F-AraG PET imaging ([18F]F-AraG PET imaging) — Amsterdam UMC, location VUmc.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| [18F]F-AraG PET imaging TARGET | [18F]F-AraG PET imaging | Amsterdam UMC, location VUmc | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- [18F]F-AraG PET imaging CI watch — RSS
- [18F]F-AraG PET imaging CI watch — Atom
- [18F]F-AraG PET imaging CI watch — JSON
- [18F]F-AraG PET imaging alone — RSS
Cite this brief
Drug Landscape (2026). [18F]F-AraG PET imaging — Competitive Intelligence Brief. https://druglandscape.com/ci/18f-f-arag-pet-imaging. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab